Is it Possible to Monitor CTEPH without Ventilation Study?

Autor: Boktor RR; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084 Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC Australia., Lee ST; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084 Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC Australia., Bom HH; Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeonnam, South Korea.

Publikováno v: Nuclear medicine and molecular imaging [Nucl Med Mol Imaging] 2024 Dec; Vol. 58 (7), pp. 389-391. Date of Electronic Publication: 2024 Jun 03.

¹⁸ F-FDG PET/CT biomarkers as predictors of long term outcomes and survival rates in patients with high risk malignant pulmonary masses/nodules treated with stereotactic ablative radiotherapy.

Autor: Boktor RR; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia. Raef.Boktor@austin.org.au.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. Raef.Boktor@austin.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. Raef.Boktor@austin.org.au., Berlangieri SU; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia., Lau E; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia.; Department of Radiology, Austin Health, Melbourne, VIC, Australia.; Department of Radiology, University of Melbourne, Melbourne, VIC, Australia., Lim A; Department of Radiation Oncology, Austin Health, Melbourne, VIC, Australia., Gong SJ; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia.; School of Engineering and Mathematical Sciences, La Trobe University, Melbourne, VIC, Australia., Li X; Department of Mathematical and Physical Sciences, La Trobe University, Melbourne, VIC, Australia., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Publikováno v: Annals of nuclear medicine [Ann Nucl Med] 2024 Sep 28. Date of Electronic Publication: 2024 Sep 28.

Impact of ¹⁸ F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative ¹³¹ I whole body scan and elevated serum thyroglobulin.

Autor: Boktor RR; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Berlangieri SU; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC Australia., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Publikováno v: Asia Oceania journal of nuclear medicine & biology [Asia Ocean J Nucl Med Biol] 2022 Winter; Vol. 10 (1), pp. 20-27.

Effect of blood glucose level on standardized uptake value (SUV) in ¹⁸ F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Autor: Eskian M; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Alavi A; University of Pennsylvania, Philadelphia, PA, USA. Abass.Alavi@uphs.upenn.edu.; Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA. Abass.Alavi@uphs.upenn.edu., Khorasanizadeh M; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Viglianti BL; Department of Nuclear Medicine and Molecular Imaging University of Michigan, Ann Arbor, MI, USA.; Department of Veterans Affairs Healthcare System, Nuclear Medicine Service, Ann Arbor, MI, USA., Jacobsson H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Barwick TD; Department of Imaging, Imperial College Healthcare NHS Trust, London, England.; Department of Surgery and Cancer, Imperial College, London, England., Meysamie A; Department of Community and Preventive Medicine, Faculty of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Yi SK; Department of Radiation Oncology, University of Arizona, Tucson, AZ, USA., Iwano S; Department of Radiology Nagoya University Graduate School of Medicine, Nagoya, Japan., Bybel B; Department of Radiology University of Manitoba, Winnipeg, Canada., Caobelli F; Department of Nuclear Medicine, Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland., Lococo F; Department of Thoracic Surgery, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy., Gea J; Hospital del Mar - IMIM. CIBERES, ISCiii, Barcelona, Spain., Sancho-Muñoz A; Hospital del Mar - IMIM. CIBERES, ISCiii, Barcelona, Spain., Schildt J; Department of Nuclear Medicine, HUS Medical Imaging Center, Helsinki University Central Hospital, Helsinki, Finland., Tatcı E; Department of Nuclear Medicine, Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey., Lapa C; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Keramida G; Department of Nuclear Medicine, Royal Brompton and Harefield Hospital, London, England., Peters M; Brighton and Sussex University Hospitals, NHS Trust, Brighton, England., Boktor RR; Lake Imaging, St. John of God Hospital, Ballarat, VIC, Australia.; National Cancer Institute, Cairo University, Giza, Egypt., John J; Superintendent Radiographer & RPS PET Centre, Thomas' Hospital, London, England., Pitman AG; University of Notre Dame, Sydney, NSW, Australia., Mazurek T; Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Rezaei N; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Jan; Vol. 46 (1), pp. 224-237. Date of Electronic Publication: 2018 Oct 22.

Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.

Autor: Boktor RR; Lake Imaging Department of Positron Emission Tomography and Nuclear Medicine at St. John of God Hospital, Ballarat, Victoria, Australia. raefriad@hotmail.com, Walker G, Stacey R, Gledhill S, Pitman AG

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 May; Vol. 54 (5), pp. 677-82. Date of Electronic Publication: 2013 Mar 19.